Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by fourbarrelson Feb 20, 2017 10:09pm

93 Views

Post# 25870651

RE:RE:RE:NF is going to TANK

bigbirdofdayst wrote: Yes proper authorities have been notified..Mattys daddy,IROC,OSC RCMP internet fraud squad.They will take you down sausage by sausage

Like I said last week at .16. Shorts will get eaten here.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week